No. of Pages: 155 | Report Code: TIPRE00016280 | Category: Life Sciences
胃腸薬には、運動促進薬、運動抑制薬、酸関連疾患用薬などがあります。一般に使用される胃腸薬は、グループとして安全であると考えられています。胃腸（GI）疾患は、胃、膵臓、直腸、大腸、食道、小腸、胆嚢、肝臓に影響を与えます。胃腸疾患の主な症状は、消化不良、胸焼け、便秘による膨満感などです。
ヨーロッパの胃腸薬市場は、2019年の127億2,185万米ドルから2027年までに178億1,081万米ドルに達すると予想されています。市場は2019年から2027年にかけて4.4%のCAGRで成長すると予想されています。胃腸（GI）疾患の有病率の上昇と生物学的製剤の開発の増加が、ヨーロッパの胃腸薬市場の成長を促進すると予想される主な要因です。ただし、市場は、予測期間中に医薬品に関連する副作用などのリスク要因の影響を受ける可能性があります。
薬剤クラスの観点からは、酸中和剤セグメントが 2019 年のヨーロッパの胃腸薬市場で最大のシェアを占めました。投与経路の観点からは、経口セグメントがヨーロッパの胃腸薬の最大のシェアを占めました。 2019年の欧州胃腸薬市場では、用途に関しては炎症性潰瘍性大腸炎セグメントが最大のシェアを占めました。流通チャネルに関しては、小売薬局セグメントが欧州胃腸薬市場で最大のシェアを占めました。 2019.
ヨーロッパの胃腸薬に関連するいくつかの主要な一次および二次供給源市場レポートは、世界保健機関 (WHO)、欧州クローン病連盟、および欧州クローン病連盟によるものです。潰瘍性大腸炎協会 (EFCCA)、 疾病管理予防センター (CDC)、 国際胃腸障害財団、国立衛生研究所 (NIH) など .
< /p>
Strategic insights for Europe Gastrointestinal Drugs involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 12,721.85 Million |
| Market Size by 2027 | US$ 17,810.81 Million |
| Global CAGR (2019 - 2027) | 4.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 薬剤クラス
|
| Regions and Countries Covered | ヨーロッパ
|
| Market leaders and key company profiles |
The regional scope of Europe Gastrointestinal Drugs refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe Gastrointestinal Drugs Market
The Europe Gastrointestinal Drugs Market is valued at US$ 12,721.85 Million in 2019, it is projected to reach US$ 17,810.81 Million by 2027.
As per our report Europe Gastrointestinal Drugs Market, the market size is valued at US$ 12,721.85 Million in 2019, projecting it to reach US$ 17,810.81 Million by 2027. This translates to a CAGR of approximately 4.4% during the forecast period.
The Europe Gastrointestinal Drugs Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Gastrointestinal Drugs Market report:
The Europe Gastrointestinal Drugs Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Gastrointestinal Drugs Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Gastrointestinal Drugs Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Gastrointestinal Drugs Market
